Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 4.12 Billion |
| USD 6.42 Billion | |
| % | |
|
Global Pertussis Market Segmentation, By Diagnosis (Blood Tests, Chest X-Ray, Nose or Throat Culture & Test, and Others), Treatment (Medication, Vaccination, Supportive Treatments, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Industry Trends and Forecast to 2033
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Pertussis Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players
|
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
“Increasing Focus on Vaccination Programs and Immunization Coverage”
Driver
“Rising Incidence of Infectious Diseases and Government Immunization Initiatives”
Restraint/Challenge
“Waning Immunity and Vaccine Hesitancy”
The market is segmented on the basis of diagnosis, treatment, route of administration, end-users, and distribution channel.
• By Diagnosis
On the basis of diagnosis, the Pertussis market is segmented into blood tests, chest X-ray, nose or throat culture & test, and others. The nose or throat culture & test segment dominated the largest market revenue share of 36.8% in 2025, driven by its high accuracy in detecting Bordetella pertussis infection and its widespread use as a standard diagnostic method. These tests are commonly recommended by healthcare professionals due to their reliability in confirming pertussis, especially in early stages of infection. Increasing awareness about timely diagnosis and rising incidence of respiratory infections are further supporting the growth of this segment. In addition, the availability of advanced laboratory infrastructure and diagnostic capabilities in hospitals and clinics contributes to higher adoption. Governments and healthcare organizations are also emphasizing early detection to prevent disease spread, further boosting demand. The segment benefits from continuous improvements in diagnostic techniques and increasing healthcare access globally.
The blood tests segment is expected to witness the fastest CAGR of 9.3% from 2026 to 2033, driven by the growing adoption of less invasive and rapid diagnostic methods. Blood tests are gaining popularity due to their ability to detect antibodies and provide supportive diagnostic information, particularly in later stages of infection. Increasing demand for quick and convenient testing solutions is a key factor accelerating segment growth. Technological advancements in diagnostic tools and the development of more sensitive assays are further enhancing their effectiveness. In addition, the expansion of diagnostic laboratories and improved healthcare infrastructure in emerging markets are contributing to increased adoption. Rising awareness about early disease detection and improved patient compliance are also expected to support growth. The segment is anticipated to expand significantly as diagnostic technologies continue to evolve.
• By Treatment
On the basis of treatment, the Pertussis market is segmented into medication, vaccination, supportive treatments, and others. The vaccination segment dominated the largest market revenue share of 42.5% in 2025, driven by strong government immunization programs and global initiatives aimed at preventing pertussis infections. Vaccination remains the most effective strategy for controlling the spread of the disease, particularly among infants and children. Increasing awareness campaigns and mandatory vaccination policies in many countries have significantly boosted uptake. In addition, the inclusion of pertussis vaccines in routine immunization schedules supports consistent demand. Pharmaceutical companies are continuously investing in the development of improved and combination vaccines, further strengthening this segment. The rising focus on preventive healthcare and increasing healthcare expenditure also contribute to its dominance.
The medication segment is expected to witness the fastest CAGR of 8.7% from 2026 to 2033, driven by the growing need for effective treatment options for infected individuals. Antibiotics such as macrolides are commonly prescribed to manage pertussis symptoms and reduce transmission. Increasing incidence of pertussis outbreaks, particularly in regions with low vaccination coverage, is boosting demand for medications. In addition, rising awareness about early treatment and improved access to healthcare services are contributing to segment growth. Continuous research and development efforts to improve therapeutic outcomes are further supporting expansion. The segment is also benefiting from increased diagnosis rates and timely medical intervention, making it one of the fastest-growing areas in the market.
• By Route of Administration
On the basis of route of administration, the Pertussis market is segmented into oral, parenteral, and others. The parenteral segment dominated the market with a revenue share of 54.1% in 2025, primarily due to the widespread use of injectable vaccines for pertussis prevention. Parenteral administration ensures effective delivery of vaccines and rapid immune response, making it the preferred route for immunization programs. The dominance of this segment is further supported by government-led vaccination campaigns and global immunization initiatives. In addition, healthcare professionals prefer injectable routes for accurate dosing and controlled administration. Increasing focus on preventive healthcare and expanding vaccination coverage globally are key factors driving growth.
The oral segment is expected to register the fastest CAGR of 9.1% from 2026 to 2033, driven by its convenience and ease of administration, particularly for pediatric and geriatric populations. Oral medications are commonly used for treating pertussis symptoms, making them a preferred option for outpatient care. The availability of oral antibiotics and supportive drugs further supports segment growth. In addition, increasing patient preference for non-invasive treatment options is contributing to rising demand. Advancements in drug formulations and improved patient compliance are also boosting adoption. The segment is expected to witness significant growth due to its accessibility and ease of use.
• By End-Users
On the basis of end-users, the Pertussis market is segmented into hospitals, homecare, specialty clinics, and others. The hospitals segment dominated the market with a share of 47.3% in 2025, as hospitals are the primary centers for diagnosis, treatment, and vaccination of pertussis. They provide access to advanced diagnostic tools, trained healthcare professionals, and comprehensive treatment facilities. Hospitals play a crucial role in managing severe cases and administering vaccines, particularly for infants and high-risk populations. Increasing hospital admissions due to respiratory infections and rising awareness about professional healthcare services are key factors supporting segment growth. In addition, government funding and improved healthcare infrastructure further strengthen this segment’s dominance.
The homecare segment is anticipated to grow at the fastest CAGR of 9.8% from 2026 to 2033, driven by the increasing preference for home-based treatment and recovery. Patients with mild to moderate symptoms often opt for homecare due to convenience and cost-effectiveness. The availability of oral medications and supportive care options enables effective treatment outside hospital settings. In addition, the rise of telehealth services and remote consultations is facilitating better disease management at home. Growing awareness about self-care and improved access to healthcare resources are further boosting segment growth. The shift towards outpatient care is expected to significantly contribute to this segment’s expansion.
• By Distribution Channel
On the basis of distribution channel, the Pertussis market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment dominated the market with a revenue share of 45.9% in 2025, driven by the high volume of vaccinations and treatments administered in hospital settings. Hospital pharmacies ensure the availability of essential medications and vaccines, particularly for inpatient care and immunization programs. They play a crucial role in maintaining drug supply chains and supporting healthcare providers. Increasing patient visits to hospitals and rising vaccination rates are key factors contributing to segment growth. In addition, government initiatives and institutional procurement further strengthen this segment.
The online pharmacy segment is expected to witness the fastest CAGR of 11.1% from 2026 to 2033, fueled by the rapid growth of digital healthcare platforms and e-commerce. Online pharmacies offer convenience, home delivery, and competitive pricing, making them increasingly popular among consumers. The rising adoption of smartphones and internet penetration is further driving this segment. In addition, the COVID-19 pandemic accelerated the shift toward online healthcare services, a trend that continues to persist. Improved regulatory frameworks and advancements in digital infrastructure are also supporting market expansion. The segment is expected to grow significantly as consumers increasingly prefer convenient and contactless purchasing options.
U.S. Pertussis Market Insight
The U.S. pertussis market captured the largest revenue share in 2025 within North America, driven by consistent demand for routine and booster vaccination programs. The country demonstrates high vaccination coverage supported by strong government initiatives and recommendations from health authorities such as the Centers for Disease Control and Prevention. Increasing awareness regarding the importance of immunization across all age groups, including pregnant women, is further boosting vaccine uptake. In addition, the presence of advanced healthcare infrastructure, ongoing surveillance programs, and continuous research and development activities are key factors propelling market growth.
Europe Pertussis Market Insight
The Europe pertussis market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by strong national immunization programs and increasing awareness of infectious diseases. Rising incidences of pertussis outbreaks in certain regions have reinforced the importance of booster vaccinations and continuous monitoring. Government initiatives, along with recommendations from organizations such as the European Centre for Disease Prevention and Control, are encouraging higher vaccination coverage. In addition, improved access to healthcare services and public health campaigns are supporting market expansion across the region.
U.K. Pertussis Market Insight
The U.K. pertussis market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by strong support from national immunization programs and increasing awareness regarding maternal vaccination. The government’s proactive approach toward protecting infants through vaccination during pregnancy is a key growth factor. Furthermore, continuous monitoring of pertussis cases and public health campaigns are encouraging timely vaccination and booster dose administration.
Germany Pertussis Market Insight
The Germany pertussis market is expected to expand at a considerable CAGR during the forecast period, supported by a well-established healthcare system and high vaccination compliance rates. Increasing awareness regarding infectious disease prevention and strong emphasis on routine immunization schedules are contributing to market growth. In addition, the country’s focus on preventive healthcare and availability of advanced vaccine options are further strengthening the market landscape.
Asia-Pacific Pertussis Market Insight
The Asia-Pacific pertussis market is expected to grow at the fastest CAGR during the forecast period, driven by expanding immunization coverage, rising birth rates, increasing healthcare investments, and improving awareness regarding vaccine-preventable diseases. Governments across countries such as China and India are actively strengthening national immunization programs to improve vaccination rates. Rising population levels and increasing number of newborns are significantly contributing to the demand for pertussis vaccines. Improvements in healthcare infrastructure and access to vaccination services are enabling broader reach, particularly in rural and underserved areas. Public health initiatives and collaborations with global organizations are further supporting large-scale immunization drives. The growing focus on preventive healthcare and increasing government spending are key factors accelerating regional market growth.
Japan Pertussis Market Insight
The Japan pertussis market is gaining momentum due to high awareness regarding infectious diseases and strong adherence to vaccination schedules. The country’s advanced healthcare system and focus on preventive care contribute to high immunization rates. In addition, the aging population and emphasis on booster vaccinations for adults are supporting sustained demand in the market. Continuous surveillance and government-led initiatives further strengthen disease prevention efforts.
China Pertussis Market Insight
The China pertussis market accounted for the largest market revenue share in Asia-Pacific in 2025, attributed to expanding immunization programs, a large population base, and increasing healthcare investments. Rising awareness regarding vaccine-preventable diseases and strong government initiatives to improve vaccination coverage are driving market growth. In addition, the presence of domestic vaccine manufacturers and increasing accessibility to affordable vaccines are further supporting the expansion of the pertussis market in China.
The Pertussis industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.